Audit Committee

We have established an audit committee on 20 October 2017 with written terms of reference in compliance with Rule 3.21 of the Listing Rules and paragraph C3 of the Code on Corporate Governance Practices as set out in Appendix 14 of the Listing Rules. The audit committee consists of three members, namely Mr. Cheng Yuk Wo, Mr. Huang Lester Garson and Dr. Lam Lee G.. The audit committee is chaired by Mr. Cheng Yuk Wo. The primary duties of the audit committee are to assist the Board by providing an independent view of the effectiveness of the financial reporting process, internal control and risk management system of our Group, to oversee the audit process, to develop and review our policies and to perform other duties and responsibilities as assigned by our Board.


Remuneration Committee

We have established a remuneration committee on 20 October 2017 with written terms of reference in compliance with Rule 3.25 of the Listing Rules and paragraph B1 of the Code on Corporate Governance Practices as set out in Appendix 14 of the Listing Rules. The remuneration committee consists of three members, namely Mr. Huang Lester Garson, Mr. Cheng Yuk Wo and Dr. Lo Wing Yan William. Two of the members which is the majority are our independent non-executive Directors. The remuneration committee is chaired by Mr. Huang Lester Garson, an independent non-executive Director. The primary duties of the remuneration committee include (but without limitation): (i) making recommendations to our Directors regarding our policy and structure for the remuneration of all our Directors and senior management and on the establishment of a formal and transparent procedure for developing remuneration policies; (ii) making recommendations to the Board on the remuneration packages of our Directors and senior management; (iii) reviewing and approving the management’s remuneration proposals with reference to the Board’s corporate goals and objectives; and (iv) considering and approving the grant of share options to eligible participants pursuant to the Post-IPO Share Option Scheme.


Nomination Committee

We have established a nomination committee on 20 October 2017 with written terms of reference. The nomination committee consists of three members, namely Dr. Lam Lee G., Mr. Cheng Yuk Wo and Mr. Huang Lester Garson. All of the members are our independent non-executive Directors. The chairman of the nomination committee is Dr. Lam Lee G. The primary function of the nomination committee is to make recommendations to our Board on the appointment of members of our Board.